Sector Corbus Pharmaceuticals Holdings, Inc.
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 8.240 USD | -7.00% |
|
-28.10% | +1.23% |
| 08-13 | Mizuho Adjusts PT on Corbus Pharmaceuticals to $33 From $34, Keeps Outperform Rating | MT |
| 08-07 | Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -7.00% | -28.10% | -12.90% | +7.01% | +1.23% | -14.70% | +21.89% | -76.92% | -94.72% | 171M | |
| -0.25% | -1.36% | -4.24% | +59.21% | +70.45% | +44.08% | +102.76% | +9.73% | - | 68.52B | |
| -1.09% | -6.20% | +11.58% | +12.16% | +19.39% | +30.50% | +76.56% | +206.74% | +5,822.49% | 62.88B | |
| -1.18% | +0.47% | -5.54% | +38.53% | -26.87% | -12.78% | +384.69% | +368.80% | +865.71% | 28.13B | |
| -2.74% | -6.31% | +2.99% | +59.93% | +51.08% | +26.33% | +13.50% | -59.95% | - | 25.56B | |
| -1.76% | -6.30% | +3.88% | +11.90% | +1.26% | -4.55% | -19.75% | -72.39% | - | 24.65B | |
| -2.39% | -5.19% | +4.57% | +29.54% | +2.76% | +17.75% | -20.95% | -25.15% | +108.30% | 19.81B | |
| -1.86% | -2.22% | -0.75% | +48.50% | +211.54% | +202.03% | +353.89% | +1,608.64% | +792.81% | 17.69B | |
| -1.37% | -4.51% | -10.24% | +18.19% | +20.96% | -5.21% | +528.34% | - | - | 14.66B | |
| -1.54% | -2.88% | +8.44% | +9.22% | +31.03% | +52.33% | +159.75% | +187.73% | +379.38% | 14.45B | |
| -3.08% | -0.76% | +14.32% | +30.27% | -2.80% | -3.44% | +1,003.90% | +161.54% | +175.08% | 13.99B | |
| -2.48% | -1.75% | +3.45% | +13.11% | -8.45% | +23.95% | +171.20% | +565.40% | +4,715.90% | 12.63B | |
| +0.16% | -4.31% | -6.31% | +17.01% | +24.66% | +186.47% | +176.79% | +29.33% | +1,055.87% | 11.67B | |
| -1.53% | +3.08% | -7.78% | +6.42% | -17.17% | -29.89% | +170.91% | +112.73% | - | 11.16B | |
| -0.66% | -0.45% | -4.99% | +9.77% | +15.86% | +41.58% | +104.16% | +149.39% | +709.90% | 10.3B | |
| -1.03% | -3.71% | +1.05% | +29.68% | +27.65% | +84.06% | +16.22% | +125.15% | - | 8.86B | |
| -4.22% | -5.74% | +3.07% | +10.60% | +289.90% | +200.39% | +498.45% | -21.94% | - | 8.54B | |
| -3.69% | -8.37% | -12.21% | +6.29% | +3.33% | -26.63% | +123.42% | -29.28% | - | 8.26B | |
| +2.05% | +1.67% | -15.78% | +18.15% | +170.79% | +448.27% | +533.64% | -47.89% | -48.94% | 7.66B | |
| -4.42% | +2.33% | +4.67% | +28.14% | +9.45% | +164.18% | +455.60% | - | - | 7.38B | |
| Average | -1.73% | -0.46% | -1.14% | +23.18% | +44.80% | +71.24% | +242.75% | +177.31% | +1,316.53% | 18.85B | |
| Weighted average by Cap. | -1.32% | -0.64% | +1.01% | +29.94% | +40.91% | +50.80% | +192.48% | +180.98% | +2,474.32% |
- Stock Market
- Stocks
- CRBP Stock
- Sector Corbus Pharmaceuticals Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
